Key facts
- This page summarizes Rutul R. Shah's Form 4 filing for PRECIGEN, INC. (PGEN).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 25 Aug 2026, 17:27.
Rutul R. Shah - 21 Aug 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- PGEN
- Reported as of
- 21 Aug 2026
- Net transaction value
- -$375,000
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2026, 17:27:09 UTC
- Prior SEC filing
- 07 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rutul R. Shah filed Form 4 for PRECIGEN, INC. (PGEN) on 25 Aug 2026.
Change
- Previous filing in this sequence was filed on 07 Aug 2026.
- Current net transaction value: -$375,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001947221
Primary reporting owner
Shah Rutul R
- Relationship
- Chief Operating Officer
- Address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
- Signature
- /s/ Rutul R. Shah, by Donald P. Lehr, as attorney-in-fact
- Signature date
- 25 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGEN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +34,658
- Change %
- +7.5%
- Price
- $2.33*
- Shares after
- 499,670
- Date
- 21 Aug 2026
- Ownership
- Direct
PGEN
transaction
Common Stock
Sale
- Transaction value
- $259,935
- Shares
- -34,658
- Change %
- -6.9%
- Price
- $7.50
- Shares after
- 465,012
- Date
- 21 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
PGEN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +7,500
- Change %
- +1.6%
- Price
- Shares after
- 472,512
- Date
- 23 Aug 2026
- Ownership
- Direct
- Footnotes
- F2
PGEN
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -3,647
- Change %
- -0.77%
- Price
- $7.20*
- Shares after
- 468,865
- Date
- 23 Aug 2026
- Ownership
- Direct
- Footnotes
- F3
PGEN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +15,342
- Change %
- +3.3%
- Price
- $2.33*
- Shares after
- 484,207
- Date
- 25 Aug 2026
- Ownership
- Direct
PGEN
transaction
Common Stock
Sale
- Transaction value
- $115,065
- Shares
- -15,342
- Change %
- -3.2%
- Price
- $7.50
- Shares after
- 468,865
- Date
- 25 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -34,658
- Change %
- -28%
- Price
- $0.000000*
- Shares after
- 88,646
- Date
- 21 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 34,658
- Exercise price
- $2.33
- Footnotes
- F4
PGEN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -7,500
- Change %
- -12%
- Price
- $0.000000*
- Shares after
- 57,292
- Date
- 23 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- Footnotes
- F2, F5
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -15,342
- Change %
- -17%
- Price
- $0.000000*
- Shares after
- 73,304
- Date
- 25 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,342
- Exercise price
- $2.33
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
Footnote F3
Represents the number of shares of Precigen common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.
Footnote F4
The stock options are fully vested.
Footnote F5
Represents 1/24 of the RSUs granted on June 26, 2025 that vested on August 23, 2026.